CALLICUTT JACK W
SEC CIK 1266773 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GALT | GALECTIN THERAPEUTICS INC | CFO | 53.7K | $5,280 | $1.04M | 15 | 2022-11-17 | 2026-01-02 |
Most active insiders at GALT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | 10X Capital Management, LLC | 10% | — | $2.23M |
| 2 | Shlevin Harold H. | Dir | — | $1.56M |
| 3 | Jamil Khurram | Chief Medical Off | — | $1.44M |
| 4 | CALLICUTT JACK W | CFO | — | $944.3K |
| 5 | LEWIS JOEL | Pres, CEO, Dir | — | $620.9K |
| 6 | CZIRR JAMES C | 10% | — | $204.3K |
| 7 | FREEMAN KEVIN D | Dir | $58.6K | — |
| 8 | ELDRED KARY | Dir | $6,032 | — |
| 9 | Uihlein Richard E | Dir, 10% | — | — |
Transactions 15
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-01-06 | 2026-01-02 | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | M - OptEx | $0.00 | +60.0K | 67.6K | +788% | $0 |
| DMT | 2026-01-06 | 2026-01-02+ | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | S - Sale+OE | $3.89 | -60.0K | 53.7K | -53% | -$233.5K |
| DMT | 2025-11-19 | 2025-11-17+ | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | M - OptEx | $1.53 | +77.9K | 25.8K | New | +$119.6K |
| DMT | 2025-11-19 | 2025-11-17+ | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | S - Sale+OE | $6.14 | -77.9K | 7,614 | -91% | -$478.7K |
| DMT | 2025-11-12 | 2025-11-10 | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | M - OptEx | $1.46 | +5,291 | 9,694 | +120% | +$7,717 |
| DMT | 2025-11-12 | 2025-11-10 | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | S - Sale+OE | $6.03 | -5,291 | 7,614 | -41% | -$31.9K |
| DMT | 2025-11-07 | 2025-11-05 | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | S - Sale+OE | $6.00 | -600 | 7,614 | -7% | -$3,600 |
| DMT | 2025-11-07 | 2025-11-05 | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | M - OptEx | $1.60 | +600 | 7,814 | +8% | +$962 |
| DMT | 2025-11-05 | 2025-11-03+ | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | M - OptEx | $1.61 | +32.4K | 8,874 | New | +$52.2K |
| DMT | 2025-11-05 | 2025-11-03+ | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | S - Sale+OE | $6.06 | -32.4K | 7,614 | -81% | -$196.7K |
| DT | 2025-09-15 | 2025-09-12 | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | M - OptEx | $1.37 | +8,706 | 16.3K | +114% | +$11.9K |
| DT | 2025-09-15 | 2025-09-12 | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | S - Sale+OE | $6.44 | -8,706 | 7,614 | -53% | -$56.1K |
| DT | 2024-12-26 | 2024-12-23 | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | M - OptEx | $0.00 | +40.0K | 47.6K | +525% | $0 |
| DT | 2024-12-26 | 2024-12-23 | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | S - Sale+OE | $0.89 | -40.0K | 7,614 | -84% | -$35.6K |
| 2022-11-17 | 2022-11-17 | GALT | GALECTIN THERAPEUTICS INC | CALLICUTT JACK W | CFO | P - Purchase | $1.32 | +4,000 | 7,614 | +111% | +$5,280 |
Purchase Sale Sale after option exercise All abbreviations